{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:30:03Z","timestamp":1784637003635,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41401-020-0473-8","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T11:03:25Z","timestamp":1595329405000},"page":"573-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Matrine attenuates pathological cardiac fibrosis via RPS5\/p38 in mice"],"prefix":"10.1038","volume":"42","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-ying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-guo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-zhu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"473_CR1","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","volume":"14","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Yuan YP, Wu HM, Zhang X, Tang QZ. Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci. 2018;14:1645\u201357.","journal-title":"Int J Biol Sci"},{"key":"473_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71:549\u201374.","journal-title":"Cell Mol Life Sci"},{"key":"473_CR3","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","volume":"71","author":"A Gonzalez","year":"2018","unstructured":"Gonzalez A, Schelbert EB, Diez J, Butler J. Myocardial interstitial fibrosis in heart failure: biological and translational perspectives. J Am Coll Cardiol. 2018;71:1696\u2013706.","journal-title":"J Am Coll Cardiol"},{"key":"473_CR4","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.jacc.2019.02.049","volume":"73","author":"CK Nagaraju","year":"2019","unstructured":"Nagaraju CK, Robinson EL, Abdesselem M, Trenson S, Dries E, Gilbert G, et al. Myofibroblast phenotype and reversibility of fibrosis in patients with end-stage heart failure. J Am Coll Cardiol. 2019;73:2267\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"473_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.118.035420","volume":"138","author":"S Park","year":"2018","unstructured":"Park S, Ranjbarvaziri S, Lay FD, Zhao P, Miller MJ, Dhaliwal JS, et al. Genetic regulation of fibroblast activation and proliferation in cardiac fibrosis. Circulation. 2018;138:1224\u201335.","journal-title":"Circulation"},{"key":"473_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ebiom.2017.03.021","volume":"18","author":"ZG Ma","year":"2017","unstructured":"Ma ZG, Yuan YP, Zhang X, Xu SC, Wang SS, Tang QZ. Piperine attenuates pathological cardiac fibrosis via PPAR-gamma\/AKT pathways. Ebiomedicine. 2017;18:179\u201387.","journal-title":"Ebiomedicine"},{"key":"473_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1042\/CS20180160","volume":"132","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Zhang X, Yuan YP, Jin YG, Li N, Kong CY, et al. A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice. Clin Sci. 2018;132:685\u201399.","journal-title":"Clin Sci"},{"key":"473_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.116.026238","volume":"136","author":"JD Molkentin","year":"2017","unstructured":"Molkentin JD, Bugg D, Ghearing N, Dorn LE, Kim P, Sargent MA, et al. Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase in vivo reveals its central regulatory role in fibrosis. Circulation. 2017;136:549\u201361.","journal-title":"Circulation"},{"key":"473_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.119.315125","volume":"125","author":"MS Stratton","year":"2019","unstructured":"Stratton MS, Bagchi RA, Felisbino MB, Hirsch RA, Smith HE, Riching AS, et al. Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation. Circ Res. 2019;125:662\u201377.","journal-title":"Circ Res"},{"key":"473_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/hep.27138","volume":"60","author":"WH Xu","year":"2014","unstructured":"Xu WH, Hu HG, Tian Y, Wang SZ, Li J, Li JZ, et al. Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis. Hepatology. 2014;60:648\u201360.","journal-title":"Hepatology"},{"key":"473_CR11","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1111\/bph.13209","volume":"172","author":"XY Zeng","year":"2015","unstructured":"Zeng XY, Wang H, Bai F, Zhou X, Li SP, Ren LP, et al. Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target. Br J Pharmacol. 2015;172:4303\u201318.","journal-title":"Br J Pharmacol"},{"key":"473_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1142\/S0192415X03001107","volume":"31","author":"J Liu","year":"2003","unstructured":"Liu J, Zhu M, Shi R, Yang M. Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials. Am J Chin Med. 2003;31:337\u201354.","journal-title":"Am J Chin Med"},{"key":"473_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.394","volume":"8","author":"X Chen","year":"2017","unstructured":"Chen X, Zhi X, Cao L, Weng W, Pan P, Hu H, et al. Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis. Cell Death Dis. 2017;8:e3037.","journal-title":"Cell Death Dis"},{"key":"473_CR14","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1096\/fj.201700316R","volume":"31","author":"X Chen","year":"2017","unstructured":"Chen X, Zhi X, Pan P, Cui J, Cao L, Weng W, et al. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. FASEB J. 2017;31:4855\u201365.","journal-title":"FASEB J"},{"key":"473_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fphar.2018.00022","volume":"9","author":"Z Xin","year":"2018","unstructured":"Xin Z, Jin C, Chao L, Zheng Z, Liehu C, Panpan P, et al. A matrine derivative M54 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by targeting ribosomal protein S5. Front Pharmacol. 2018;9:22.","journal-title":"Front Pharmacol"},{"key":"473_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2015.07.035","volume":"368","author":"L Qian","year":"2015","unstructured":"Qian L, Liu Y, Xu Y, Ji W, Wu Q, Liu Y, et al. Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR\/ERK\/MMP-2 and PTEN\/AKT signaling pathways. Cancer Lett. 2015;368:126\u201334.","journal-title":"Cancer Lett"},{"key":"473_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/aps.2016.104","volume":"38","author":"Y Liu","year":"2017","unstructured":"Liu Y, Qi Y, Bai ZH, Ni CX, Ren QH, Xu WH, et al. A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K\/AKT signaling pathways. Acta Pharmacol Sin. 2017;38:120\u201332.","journal-title":"Acta Pharmacol Sin"},{"key":"473_CR18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3390\/molecules24061108","volume":"24","author":"L Li","year":"2019","unstructured":"Li L, Ma L, Wang D, Jia H, Yu M, Gu Y, et al. Design and synthesis of matrine derivatives as novel anti-pulmonary fibrotic agents via repression of the TGF-beta\/Smad pathway. Molecules. 2019;24:1108.","journal-title":"Molecules"},{"key":"473_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s13238-016-0285-2","volume":"7","author":"Y Feng","year":"2016","unstructured":"Feng Y, Ying HY, Qu Y, Cai XB, Xu MY, Lu LG. Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells. Protein Cell. 2016;7:662\u201372.","journal-title":"Protein Cell"},{"key":"473_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.apsb.2019.03.003","volume":"9","author":"C Hu","year":"2019","unstructured":"Hu C, Zhang X, Wei W, Zhang N, Wu H, Ma Z, et al. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKalpha\/UCP2 pathway. Acta Pharm Sin B. 2019;9:690\u2013701.","journal-title":"Acta Pharm Sin B"},{"key":"473_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0123-3","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ma ZG, Yuan YP, Xu SC, Wei WY, Song P, et al. Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKalpha\/Smad3 signaling. Cell Death Dis. 2018;9:102.","journal-title":"Cell Death Dis"},{"key":"473_CR22","doi-asserted-by":"publisher","first-page":"47040","DOI":"10.1074\/jbc.M404595200","volume":"279","author":"R Diskin","year":"2004","unstructured":"Diskin R, Askari N, Capone R, Engelberg D, Livnah O. Active mutants of the human p38alpha mitogen-activated protein kinase. J Biol Chem. 2004;279:47040\u20139.","journal-title":"J Biol Chem"},{"key":"473_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/cr.2012.143","volume":"23","author":"X Xu","year":"2013","unstructured":"Xu X, Wang Q, Long Y, Zhang R, Wei X, Xing M, et al. Stress-mediated p38 activation promotes somatic cell reprogramming. Cell Res. 2013;23:131\u201341.","journal-title":"Cell Res"},{"key":"473_CR24","doi-asserted-by":"crossref","first-page":"6053727","DOI":"10.1155\/2018\/6053727","volume":"2018","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Kong CY, Song P, Zhang X, Yuan YP, Tang QZ. Geniposide protects against obesity-related cardiac injury through AMPKalpha- and Sirt1-dependent mechanisms. Oxid Med Cell Longev. 2018;2018:6053727.","journal-title":"Oxid Med Cell Longev"},{"key":"473_CR25","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s00125-017-4232-4","volume":"60","author":"ZG Ma","year":"2017","unstructured":"Ma ZG, Yuan YP, Xu SC, Wei WY, Xu CR, Zhang X, et al. CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats. Diabetologia. 2017;60:1126\u201337.","journal-title":"Diabetologia"},{"key":"473_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.7150\/ijbs.29907","volume":"15","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhu JX, Ma ZG, Wu HM, Xu SC, Song P, et al. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity. Int J Biol Sci. 2019;15:556\u201367.","journal-title":"Int J Biol Sci"},{"key":"473_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.yjmcc.2017.10.008","volume":"114","author":"YP Yuan","year":"2018","unstructured":"Yuan YP, Ma ZG, Zhang X, Xu SC, Zeng XF, Yang Z, et al. CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1. J Mol Cell Cardiol. 2018;114:38\u201347.","journal-title":"J Mol Cell Cardiol"},{"key":"473_CR28","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/s41418-018-0109-4","volume":"25","author":"X Wang","year":"2018","unstructured":"Wang X, Bi X, Zhang G, Deng Y, Luo X, Xu L, et al. Glucose-regulated protein 78 is essential for cardiac myocyte survival. Cell Death Differ. 2018;25:2181\u201394.","journal-title":"Cell Death Differ"},{"key":"473_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/jce.13448","volume":"29","author":"J Ma","year":"2018","unstructured":"Ma J, Ma S, Yin C, Wu H. Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties. J Cardiovasc Electrophysiol. 2018;29:616\u201327.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"473_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/SHK.0000000000001108","volume":"50","author":"S Guo","year":"2018","unstructured":"Guo S, Gao C, Xiao W, Zhang J, Qu Y, Li J, et al. Matrine protects cardiomyocytes from ischemia\/reperfusion injury by regulating HSP70 expression via activation of the JAK2\/STAT3 pathway. Shock. 2018;50:664\u201370.","journal-title":"Shock"},{"key":"473_CR31","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/cdd.2017.103","volume":"24","author":"L Avalle","year":"2017","unstructured":"Avalle L, Incarnato D, Savino A, Gai M, Marino F, Pensa S, et al. MicroRNAs-143 and -145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins. Cell Death Differ. 2017;24:1750\u201360.","journal-title":"Cell Death Differ"},{"key":"473_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/cdd.2017.158","volume":"25","author":"J Beermann","year":"2018","unstructured":"Beermann J, Kirste D, Iwanov K, Lu D, Kleemiss F, Kumarswamy R, et al. A large shRNA library approach identifies lncRNA Ntep as an essential regulator of cell proliferation. Cell Death Differ. 2018;25:307\u201318.","journal-title":"Cell Death Differ"},{"key":"473_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01955-w","volume":"8","author":"F Qu","year":"2017","unstructured":"Qu F, Holloway JL, Esterhai JL, Burdick JA, Mauck RL. Programmed biomolecule delivery to enable and direct cell migration for connective tissue repair. Nat Commun. 2017;8:1780.","journal-title":"Nat Commun"},{"key":"473_CR34","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41418-018-0086-7","volume":"25","author":"H Zhou","year":"2018","unstructured":"Zhou H, Zhu P, Wang J, Zhu H, Ren J, Chen Y. Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2alpha-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy. Cell Death Differ. 2018;25:1080\u201393.","journal-title":"Cell Death Differ"},{"key":"473_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.apsb.2018.01.001","volume":"8","author":"W Jin","year":"2018","unstructured":"Jin W, Cui B, Li P, Hua F, Lv X, Zhou J, et al. 1,25-Dihydroxyvitamin D3 protects obese rats from metabolic syndrome via promoting regulatory T cell-mediated resolution of inflammation. Acta Pharm Sin B. 2018;8:178\u201387.","journal-title":"Acta Pharm Sin B"},{"key":"473_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","volume":"27","author":"X Zhang","year":"2020","unstructured":"Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020;27:540\u201355.","journal-title":"Cell Death Differ"},{"key":"473_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacc.2015.10.063","volume":"67","author":"B Lopez","year":"2016","unstructured":"Lopez B, Ravassa S, Gonzalez A, Zubillaga E, Bonavila C, Berges M, et al. Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure. J Am Coll Cardiol. 2016;67:251\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"473_CR38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/abbs\/gmu101","volume":"46","author":"H Ren","year":"2014","unstructured":"Ren H, Zhang S, Ma H, Wang Y, Liu D, Wang X, et al. Matrine reduces the proliferation and invasion of colorectal cancer cells via reducing the activity of p38 signaling pathway. Acta Biochim Biophys Sin. 2014;46:1049\u201355.","journal-title":"Acta Biochim Biophys Sin"},{"key":"473_CR39","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3892\/or.2017.5787","volume":"38","author":"X Wu","year":"2017","unstructured":"Wu X, Zhou J, Cai D, Li M. Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway. Oncol Rep. 2017;38:1312\u201320.","journal-title":"Oncol Rep"},{"key":"473_CR40","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1111\/bph.13002","volume":"172","author":"W Qin","year":"2015","unstructured":"Qin W, Du N, Zhang L, Wu X, Hu Y, Li X, et al. Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice. Br J Pharmacol. 2015;172:5559\u201372.","journal-title":"Br J Pharmacol"},{"key":"473_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fphar.2019.00405","volume":"10","author":"A Mahzari","year":"2019","unstructured":"Mahzari A, Li S, Zhou X, Li D, Fouda S, Alhomrani M, et al. Matrine protects against MCD-induced development of NASH via upregulating HSP72 and downregulating mTOR in a manner distinctive from metformin. Front Pharmacol. 2019;10:405.","journal-title":"Front Pharmacol"},{"key":"473_CR42","first-page":"1775","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Cui L, Guan G, Wang J, Qiu C, Yang T, et al. Matrine suppresses cardiac fibrosis by inhibiting the TGFbeta\/Smad pathway in experimental diabetic cardiomyopathy. Mol Med Rep. 2018;17:1775\u201381.","journal-title":"Mol Med Rep"},{"key":"473_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2017.03.061","volume":"804","author":"Z Liu","year":"2017","unstructured":"Liu Z, Zhang Y, Tang Z, Xu J, Ma M, Pan S, et al. Matrine attenuates cardiac fibrosis by affecting ATF6 signaling pathway in diabetic cardiomyopathy. Eur J Pharmacol. 2017;804:21\u201330.","journal-title":"Eur J Pharmacol"},{"key":"473_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","volume":"90","author":"I Russo","year":"2016","unstructured":"Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2016;90:84\u201393.","journal-title":"J Mol Cell Cardiol"},{"key":"473_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61:21\u20138.","journal-title":"Diabetologia"},{"key":"473_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/CIRCRESAHA.116.309398","volume":"120","author":"M Appari","year":"2017","unstructured":"Appari M, Breitbart A, Brandes F, Szaroszyk M, Froese N, Korf-Klingebiel M, et al. C1q-TNF-related protein-9 promotes cardiac hypertrophy and failure. Circ Res. 2017;120:66\u201377.","journal-title":"Circ Res"},{"key":"473_CR47","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1161\/CIRCULATIONAHA.112.000010","volume":"128","author":"Y Sun","year":"2013","unstructured":"Sun Y, Yi W, Yuan Y, Lau WB, Yi D, Wang X, et al. C1q\/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation. Circulation. 2013;128:S113\u201320.","journal-title":"Circulation"},{"key":"473_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.apsb.2016.06.003","volume":"7","author":"Z Guo","year":"2017","unstructured":"Guo Z. The modification of natural products for medical use. Acta Pharm Sin B. 2017;7:119\u201336.","journal-title":"Acta Pharm Sin B"},{"key":"473_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577\u201384.","journal-title":"Nature"},{"key":"473_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/cvr\/cvr159","volume":"92","author":"L Yan","year":"2011","unstructured":"Yan L, Wei X, Tang QZ, Feng J, Zhang Y, Liu C, et al. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT\/GSK3beta and TGF-beta1-Smad signalling. Cardiovasc Res. 2011;92:85\u201394.","journal-title":"Cardiovasc Res"},{"key":"473_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCRESAHA.109.216101","volume":"107","author":"M Dobaczewski","year":"2010","unstructured":"Dobaczewski M, Bujak M, Li N, Gonzalez-Quesada C, Mendoza LH, Wang XF, et al. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res. 2010;107:418\u201328.","journal-title":"Circ Res"},{"key":"473_CR52","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.devcel.2012.08.017","volume":"23","author":"J Davis","year":"2012","unstructured":"Davis J, Burr AR, Davis GF, Birnbaumer L, Molkentin JD. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell. 2012;23:705\u201315.","journal-title":"Dev Cell"},{"key":"473_CR53","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.12659\/MSM.917151","volume":"25","author":"J Zhou","year":"2019","unstructured":"Zhou J, Ma W, Wang X, Liu H, Miao Y, Wang J, et al. Matrine suppresses reactive oxygen species (ROS)-mediated MKKs\/p38-induced inflammation in oxidized low-density lipoprotein (ox-LDL)-stimulated macrophages. Med Sci Monit. 2019;25:4130\u20136.","journal-title":"Med Sci Monit"},{"key":"473_CR54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/jmcb\/mjv014","volume":"7","author":"X Zhou","year":"2015","unstructured":"Zhou X, Liao WJ, Liao JM, Liao P, Lu H. Ribosomal proteins: functions beyond the ribosome. J Mol Cell Biol. 2015;7:92\u2013104.","journal-title":"J Mol Cell Biol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0473-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T12:58:08Z","timestamp":1723294688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0473-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-0473-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"23 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}